JunYinMD

Psychiatry • Houston, TX

Child & Adolescent Psychiatry

Physician

Join to view full profile

Dr. Yin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yin's full profile

Already have an account?

Office
10623 Bellaire Blvd
Ste C280
Houston, TX 77072
Phone+1 713-486-5900

Fax+1 713-486-5901

Education & Training

Carilion Clinic-Virginia Tech Carilion School of MedicineFellowship, Child and Adolescent Psychiatry, 2014 - 2016
Louisiana State University (Shreveport)Residency, Psychiatry, 2011 - 2014
LSU School of Medicine in ShreveportPost-Doctoral Fellowship, 2005 - 2010
Drexel University College of MedicinePh.D., Molecular and Cell Biology and Genetics Program, 2000 - 2005
Tianjin Medical UniversityClass of 2000

Certifications & Licensure

TX State Medical License 2016 - 2025
VA State Medical License 2014 - 2018
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
American Board of Psychiatry and NeurologyChild and Adolescent Psychiatry

Publications & Presentations

PubMed

14 citations
Genetic determinants of switchgrass-root-associated microbiota in field sites spanning its natural range.
Joseph A Edwards, Usha Bishnoi Saran, Jason Bonnette, Alice MacQueen, Jun Yin
Current Biology. 2023-05-22
3 citations
Natural variation in growth and leaf ion homeostasis in response to salinity stress in.
Taslima Haque, Govinal Badiger Bhaskara, Jun Yin, Jason Bonnette, Thomas E Juenger
Frontiers in Plant Science. 2022-01-01
22 citations
Natural variation in plant telomere length is associated with flowering time.
Jae Young Choi, Liliia R. Abdulkina, Jun Yin, Inna B. Chastukhina, John T. Lovell
The Plant Cell. 2021-05-31

Lectures

Prognostic and predictive impact of primary tumor sidedness in first-line trials for advanced colorectal cancer: An analysis of 7,828 patients in the ARCAD database.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

Graphite Offers up New Quantum SurpriseFebruary 25th, 2019
Hiroaki Kiyokawa, M.D., Ph.D.June 16th, 2021

Professional Memberships